Exploring the Efficacy and Safety of Polatuzumab-Vedotin

This chapter delves into the FDA-approved drug polatuzumab-vedotin for treating relapsed refractory diffuse large B-cell lymphoma. It examines the drug's mechanism, administration, precautions, and the efficacy results that support its use over traditional treatments.